Variation name (cDNA level) | Variation name (protein level) | Variation status | Variation class |
c.IVS18+2T>C (c.2293+2T>C) | Heterozygous | Mutation |
wt codon | wt aa | mutant codon | mutant aa | mutational event | mutation type |
GAT | Asp | spl+2 | Spl. | T->C | Ts |
Structure | Key Residue (HCD) | Pyrimidin doublet | CpG |
cb EGF-like #08 | Ca2+ binding |
At the mRNA level | On restriction map |
Skipping of exon 18, in frame | New restriction site(s): none Lost restriction site(s): none |
Impact on splicing | ||||||||||
Splice site type | Wild type sequence | CV | Mutant type sequence | CV | Variation (%) | |||||
TTGgtgaga |
| TTGgcgaga |
| -29.9 % |
Sample ID | Patient status | Gender | Transmission | Age of onset | Age of death | Geographic origin |
USA03STA F0005 I835 | Proband | NA | de novo | ? | U.S.A |
Phenotypic group | Disease |
Type IV | Incomplete MFS |
Symptom |
C-Mitral valve prolapse |
S-Arachnodactyly (M) |
S-Dolichostenomelia |
S-High arched palate |
S-Joint hypermobility (m) |
Reference ID | PubMed ID | Reference |
28 | 8894692 | Liu W, Qian C, Comeau K, Brenn T, Furthmayr H, Francke U. "Mutant fibrillin-1 monomers lacking EGF-like domains disrupt microfibril assembly and cause severe marfan syndrome". Hum Mol Genet 1996 Oct;5(10):1581-7 . |